Skip to main content

Table 3 Effects of E. fluctuans on lipid profile and atherogenic index in the study subjects

From: Glucose and lipid lowering effects of Enhydra fluctuans extract in cadmium treated normal and type-2 diabetic model rats

Para-meters

Days

N-C

N-Cd

N-P

N-PCd

DM-P

DMP-Cd

Chol (mg/dl)

0 day

75 ± 19

72 ± 18

76 ± 18

73 ± 15

75 ± 15

75 ± 10

21 day

67 ± 8

75 ± 8

68 ± 7

68 ± 15

84 ± 12

73 ± 13

TG (mg/dl)

0 day

58 ± 18

57 ± 15

55 ± 13

62 ± 21

53 ± 5

83 ± 12

21 day

51 ± 8

50 ± 12

48 ± 18

61 ± 18

56 ± 10

56 ± 12

HDL-C (mg/dl)

0 day

65 ± 15

64 ± 16

59 ± 9

65 ± 17

67 ± 14

58 ± 4

21 day

65 ± 11

70 ± 7

64 ± 7

63 ± 15

78 ± 10

68 ± 13

TG/HDL-C ratio

0 day

0.75 (0.49–2.38)

0.84(0.62–1.41)

0.89(0.74–1.24)

0.90(0.59–1.92)

0.83(0.66–0.98)

1.57(1.07–1.64)

21 day

0.74(0.60–1.15)

0.65(0.60–1.12)

0.66(0.48–1.27)*

0.82(0.62–1.89)

0.74(0.47–0.96)

0.81(0.63–1.08)*

  1. Results are expressed as Mean ± SD or Median (range) as appropriate. Statistical analysis within groups was done using paired t-test and WilCoxon rank sum test. SD, Standard deviation; * and ** indicate statistically significant (p < 0.05 and p < 0.01) levels from a paired t-test